Yahoo · Nov 14, 2026
Better Biotech ETF: First Trust's FBT vs. Invesco's PBE
Both biotech ETFs hold about 30 healthcare names, but their index methods and fees differ enough to shape results for investors weighing sector exposure.

NASDAQ · IVZ
Financial Services · Asset Management
$28.65
Down-$0.29 (-1.00%)
Updated Nov 19, 2026, 3:09 AM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · IVZ
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 18, 2026
IVZ closed at $28.65 after 21 trading sessions, down 2.05% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | $28.795 | $29.255 | $28.425 | $28.65 | 6.34M |
| Nov 17, 2026 | $28.63 | $29.21 | $28.20 | $28.94 | 7.12M |
| Nov 16, 2026 | $28.41 | $29.47 | $28.22 | $28.49 | 8.48M |
| Nov 13, 2026 | $28.47 | $28.96 | $27.96 | $28.92 | 6.19M |
| Nov 12, 2026 | $28.48 | $28.895 | $27.93 | $28.47 | 6.52M |
| Nov 11, 2026 | $28.45 | $28.97 | $27.81 | $28.63 | 4.89M |
| Nov 10, 2026 | $28.94 | $29.06 | $28.42 | $28.87 | 4.65M |
| Nov 9, 2026 | $27.79 | $29.10 | $27.58 | $28.91 | 7.85M |
| Nov 6, 2026 | $27.30 | $27.69 | $27.03 | $27.08 | 5.09M |
| Nov 5, 2026 | $29.63 | $29.735 | $26.885 | $27.08 | 8.82M |
| Nov 4, 2026 | $28.91 | $29.47 | $28.47 | $29.44 | 4.97M |
| Nov 3, 2026 | $27.84 | $28.295 | $27.59 | $28.26 | 4.45M |
| Nov 2, 2026 | $27.89 | $28.675 | $27.63 | $27.77 | 6.12M |
| Oct 30, 2026 | $28.64 | $28.64 | $27.38 | $27.76 | 5.86M |
| Oct 29, 2026 | $28.95 | $29.31 | $28.8939 | $29.02 | 3.84M |
| Oct 28, 2026 | $28.88 | $28.91 | $28.20 | $28.68 | 5.72M |
| Oct 27, 2026 | $28.55 | $29.20 | $28.37 | $28.43 | 6.75M |
| Oct 26, 2026 | $28.28 | $28.84 | $28.065 | $28.53 | 8.48M |
| Oct 23, 2026 | $28.41 | $28.565 | $28.02 | $28.06 | 8.26M |
| Oct 22, 2026 | $28.72 | $29.38 | $28.51 | $28.79 | 6.08M |
| Oct 21, 2026 | $29.22 | $29.44 | $27.72 | $29.25 | 5.29M |
The latest Smart Investors Daily articles mentioning IVZ.
Company
Market Activity
Research & News
IVZ research
Company profile and research snapshot.
Invesco provides investment-management services to retail (70% of managed assets) and institutional (30%) clients. At the end of September 2025, the firm had $2.125 trillion in assets under management spread among its equity (60% of AUM), balanced (3%), fixed-income (21%), alternative investment (6%), and money market (10%) operations. Passive products account for 47% of Invesco's total AUM. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 31% of its AUM sourced from Europe, Africa, and the Middle East (16%) and Asia (15%).
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 17, 2026 | Mizuho | Outperform | — |
| Nov 6, 2026 | Evercore ISI Group | In-Line | — |
| Oct 28, 2026 | Barclays | Equal-Weight | — |
| Oct 22, 2026 | Morgan Stanley | Equal-Weight | — |
| Oct 13, 2026 | BMO Capital | Outperform | — |
No generated briefing is available yet.
Yahoo · Nov 14, 2026
Both biotech ETFs hold about 30 healthcare names, but their index methods and fees differ enough to shape results for investors weighing sector exposure.
Yahoo · Nov 14, 2026
If Invesco was on your watchlist rather than in your portfolio over the past year, the gain may feel like it slipped through your fingers. Holding Invesco over the past year would have returned 26.7%, including dividends. The result invites a simple question. What clues in late 2025, such as bullish analysts expecting profit margins to climb toward 24.0% even while modeling falling revenue, could have signalled that operating efficiency rather than top line growth was the key assumption to...
Yahoo · Nov 13, 2026
Why Invesco is in focus after its new ETF launch Invesco (IVZ) put its quantitative investing arm back in the spotlight with the launch of four systematic active ETFs that aim to beat their respective equity benchmarks using factor based stock selection. Recent trading has been choppy. Invesco’s share price has slipped about 12.5% over the past 90 days and is roughly flat over the last month, yet the year to date share price return is positive and the 1 year and 3 year total shareholder...
Yahoo · Nov 13, 2026
Invesco has delivered a 135.0% return over the past three years, which puts fresh attention on a basic question. Is the current share price consistent with the returns the asset manager earns on the capital it deploys into its business? A 135.0% gain over three years puts meaningful pressure on the idea that Invesco's market value and the returns it earns on its capital are moving in step. The launch of four new systematic active ETFs managed by the Invesco Quantitative Strategies team can...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IVZ.